Moreover, currently ongoing trials do not specifically focus on early diabetes as a target of intervention and we therefore believe that our study will contribute to a better understanding of cardiovascular effects of DPP-4 inhibitors in early diabetes. The gene discussed is DPP4; the disease is diabetes mellitus.